FDA Compounding Quality CoE Launches Free Self-Guided GMP Training Curriculum for Sterile Manufacturers

The FDA Compounding Quality Center of Excellence has expanded its no-cost, self-guided online training catalogue, giving QA directors and compliance leads at outsourcing facilities and sterile drug production sites structured, CE-accredited instruction across the core disciplines that drive inspection outcomes.

The curriculum spans ten modules, with individual course loads ranging from 30 minutes to five hours. Topics map directly to recurring FDA 483 observation categories: aseptic process simulations, sterility assurance, insanitary conditions, CAPA methodology, stability programmes, and beyond-use date validation. A dedicated Outsourcing Facility Guide module addresses section 503B of the Federal Food, Drug, and Cosmetic Act, registration pathways, and adverse event reporting obligations, areas where documentation gaps have historically drawn warning letters.

For QA leads managing personnel qualification programmes, the airflow and cleanroom design module (4 CE hours) and the personnel gowning module (0.5 CE hours) provide structured content that can be embedded into site onboarding or periodic requalification cycles without incremental budget. The visual inspection module is explicitly positioned as preparation for instructor-led training, signalling that the CoE intends the self-guided content to feed into broader competency frameworks rather than stand alone.

The investigations and CAPA module, at five hours, is the most substantive offering in the catalogue. It covers trigger identification, investigative tooling, CAPA development and implementation, and effectiveness verification, a sequence that aligns with ICH Q10 pharmaceutical quality system expectations and the CAPA documentation standards inspectors assess under 21 CFR Part 211. Facilities under active corrective action commitments may find the structured walkthrough useful for staff refreshers ahead of follow-up inspections.

Continuing education credits are available to pharmacists, pharmacy technicians, physicians, and nurses, broadening the addressable audience beyond QA personnel to clinical and compounding staff whose gowning and visual inspection practices directly affect sterility assurance outcomes.

Completion rates across the full catalogue will serve as a measurable indicator of how broadly outsourcing facilities integrate the CoE's framework into their ongoing GMP training infrastructure.

Source: FDA Compounding Quality Center of Excellence via FDA Drugs RSS Feed, 14 May 2026.